nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.0568	0.082	CbGbCtD
Vinblastine—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.049	0.0708	CbGbCtD
Vinblastine—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.043	0.0622	CbGbCtD
Vinblastine—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.043	0.0622	CbGbCtD
Vinblastine—SLC22A2—Zidovudine—acquired immunodeficiency syndrome	0.0374	0.054	CbGbCtD
Vinblastine—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0363	0.0524	CbGbCtD
Vinblastine—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0319	0.0461	CbGbCtD
Vinblastine—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0319	0.046	CbGbCtD
Vinblastine—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0319	0.046	CbGbCtD
Vinblastine—SLC22A2—Lamivudine—acquired immunodeficiency syndrome	0.0289	0.0418	CbGbCtD
Vinblastine—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0236	0.0341	CbGbCtD
Vinblastine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0152	0.0219	CbGbCtD
Vinblastine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0152	0.0219	CbGbCtD
Vinblastine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0143	0.0206	CbGbCtD
Vinblastine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0143	0.0206	CbGbCtD
Vinblastine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0137	0.0198	CbGbCtD
Vinblastine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0129	0.0187	CbGbCtD
Vinblastine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0129	0.0187	CbGbCtD
Vinblastine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0118	0.0171	CbGbCtD
Vinblastine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0115	0.0166	CbGbCtD
Vinblastine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0111	0.0161	CbGbCtD
Vinblastine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0108	0.0156	CbGbCtD
Vinblastine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0104	0.015	CbGbCtD
Vinblastine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0104	0.015	CbGbCtD
Vinblastine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00996	0.0144	CbGbCtD
Vinblastine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00979	0.0141	CbGbCtD
Vinblastine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00979	0.0141	CbGbCtD
Vinblastine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00966	0.014	CbGbCtD
Vinblastine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00908	0.0131	CbGbCtD
Vinblastine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00908	0.0131	CbGbCtD
Vinblastine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00821	0.0119	CbGbCtD
Vinblastine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00821	0.0119	CbGbCtD
Vinblastine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0077	0.0111	CbGbCtD
Vinblastine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00709	0.0102	CbGbCtD
Vinblastine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00688	0.00994	CbGbCtD
Vinblastine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00622	0.00899	CbGbCtD
Vinblastine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00622	0.00899	CbGbCtD
Vinblastine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00597	0.00862	CbGbCtD
Vinblastine—TUBB1—blood plasma—acquired immunodeficiency syndrome	0.00238	0.0211	CbGeAlD
Vinblastine—TUBA1A—nerve—acquired immunodeficiency syndrome	0.00229	0.0203	CbGeAlD
Vinblastine—JUN—nerve—acquired immunodeficiency syndrome	0.00227	0.0201	CbGeAlD
Vinblastine—ABCC6—blood plasma—acquired immunodeficiency syndrome	0.00205	0.0182	CbGeAlD
Vinblastine—JUN—endothelium—acquired immunodeficiency syndrome	0.00193	0.0171	CbGeAlD
Vinblastine—TUBA1A—Zalcitabine—Didanosine—acquired immunodeficiency syndrome	0.00171	0.339	CbGdCrCtD
Vinblastine—TUBG1—retina—acquired immunodeficiency syndrome	0.00164	0.0145	CbGeAlD
Vinblastine—TUBB8—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.00163	0.0551	CbGpPWpGaD
Vinblastine—TUBG1—skin of body—acquired immunodeficiency syndrome	0.00144	0.0128	CbGeAlD
Vinblastine—TUBA1A—Zidovudine—Stavudine—acquired immunodeficiency syndrome	0.00143	0.284	CbGdCrCtD
Vinblastine—TUBD1—digestive system—acquired immunodeficiency syndrome	0.00137	0.0122	CbGeAlD
Vinblastine—TUBD1—blood—acquired immunodeficiency syndrome	0.00131	0.0116	CbGeAlD
Vinblastine—TUBE1—digestive system—acquired immunodeficiency syndrome	0.00128	0.0114	CbGeAlD
Vinblastine—TUBD1—bone marrow—acquired immunodeficiency syndrome	0.00126	0.0112	CbGeAlD
Vinblastine—TUBD1—spinal cord—acquired immunodeficiency syndrome	0.00126	0.0112	CbGeAlD
Vinblastine—TUBE1—blood—acquired immunodeficiency syndrome	0.00122	0.0109	CbGeAlD
Vinblastine—TUBD1—vagina—acquired immunodeficiency syndrome	0.00121	0.0107	CbGeAlD
Vinblastine—TUBE1—bone marrow—acquired immunodeficiency syndrome	0.00118	0.0105	CbGeAlD
Vinblastine—TUBE1—spinal cord—acquired immunodeficiency syndrome	0.00118	0.0105	CbGeAlD
Vinblastine—TUBG1—digestive system—acquired immunodeficiency syndrome	0.00115	0.0102	CbGeAlD
Vinblastine—TUBD1—lung—acquired immunodeficiency syndrome	0.00114	0.0102	CbGeAlD
Vinblastine—NR5A1—lymphoid tissue—acquired immunodeficiency syndrome	0.00114	0.0101	CbGeAlD
Vinblastine—TUBE1—vagina—acquired immunodeficiency syndrome	0.00113	0.0101	CbGeAlD
Vinblastine—ABCC6—retina—acquired immunodeficiency syndrome	0.00112	0.00995	CbGeAlD
Vinblastine—TUBG1—blood—acquired immunodeficiency syndrome	0.0011	0.00972	CbGeAlD
Vinblastine—TUBE1—lung—acquired immunodeficiency syndrome	0.00107	0.00952	CbGeAlD
Vinblastine—TUBG1—bone marrow—acquired immunodeficiency syndrome	0.00106	0.00941	CbGeAlD
Vinblastine—TUBB8—nervous system—acquired immunodeficiency syndrome	0.00106	0.0094	CbGeAlD
Vinblastine—TUBG1—spinal cord—acquired immunodeficiency syndrome	0.00106	0.00937	CbGeAlD
Vinblastine—TUBA1A—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.00102	0.0347	CbGpPWpGaD
Vinblastine—TUBB8—central nervous system—acquired immunodeficiency syndrome	0.00102	0.00905	CbGeAlD
Vinblastine—TUBG1—vagina—acquired immunodeficiency syndrome	0.00102	0.00901	CbGeAlD
Vinblastine—TUBE1—nervous system—acquired immunodeficiency syndrome	0.000993	0.00882	CbGeAlD
Vinblastine—TUBG1—lung—acquired immunodeficiency syndrome	0.00096	0.00852	CbGeAlD
Vinblastine—TUBE1—central nervous system—acquired immunodeficiency syndrome	0.000956	0.00849	CbGeAlD
Vinblastine—TUBA1A—retina—acquired immunodeficiency syndrome	0.000948	0.00841	CbGeAlD
Vinblastine—TUBB3—lymphoid tissue—acquired immunodeficiency syndrome	0.000946	0.0084	CbGeAlD
Vinblastine—JUN—retina—acquired immunodeficiency syndrome	0.000939	0.00833	CbGeAlD
Vinblastine—TUBB3—digestive system—acquired immunodeficiency syndrome	0.000935	0.0083	CbGeAlD
Vinblastine—TUBA1A—Zalcitabine—Lamivudine—acquired immunodeficiency syndrome	0.000896	0.178	CbGdCrCtD
Vinblastine—TUBB3—blood—acquired immunodeficiency syndrome	0.000891	0.0079	CbGeAlD
Vinblastine—TUBG1—nervous system—acquired immunodeficiency syndrome	0.000889	0.00789	CbGeAlD
Vinblastine—TUBB1—blood—acquired immunodeficiency syndrome	0.000871	0.00773	CbGeAlD
Vinblastine—NR5A1—nervous system—acquired immunodeficiency syndrome	0.000867	0.0077	CbGeAlD
Vinblastine—TUBG1—central nervous system—acquired immunodeficiency syndrome	0.000856	0.0076	CbGeAlD
Vinblastine—TUBB1—bone marrow—acquired immunodeficiency syndrome	0.000843	0.00748	CbGeAlD
Vinblastine—NR5A1—central nervous system—acquired immunodeficiency syndrome	0.000835	0.00741	CbGeAlD
Vinblastine—TUBA1A—skin of body—acquired immunodeficiency syndrome	0.000832	0.00739	CbGeAlD
Vinblastine—JUN—skin of body—acquired immunodeficiency syndrome	0.000824	0.00731	CbGeAlD
Vinblastine—TUBB6—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.000822	0.0279	CbGpPWpGaD
Vinblastine—TUBB2B—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.000822	0.0279	CbGpPWpGaD
Vinblastine—TUBB—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.000814	0.0276	CbGpPWpGaD
Vinblastine—TUBB4A—retina—acquired immunodeficiency syndrome	0.00081	0.00719	CbGeAlD
Vinblastine—TUBD1—brain—acquired immunodeficiency syndrome	0.00081	0.00719	CbGeAlD
Vinblastine—TUBB8—brain—acquired immunodeficiency syndrome	0.00081	0.00719	CbGeAlD
Vinblastine—TUBB3—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.000794	0.0269	CbGpPWpGaD
Vinblastine—TUBB2B—retina—acquired immunodeficiency syndrome	0.000783	0.00695	CbGeAlD
Vinblastine—TUBD1—lymph node—acquired immunodeficiency syndrome	0.000783	0.00694	CbGeAlD
Vinblastine—TUBB3—lung—acquired immunodeficiency syndrome	0.000781	0.00693	CbGeAlD
Vinblastine—TUBB2A—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.000769	0.0261	CbGpPWpGaD
Vinblastine—TUBE1—brain—acquired immunodeficiency syndrome	0.000759	0.00674	CbGeAlD
Vinblastine—TUBB1—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.000752	0.0255	CbGpPWpGaD
Vinblastine—ABCC6—blood—acquired immunodeficiency syndrome	0.00075	0.00665	CbGeAlD
Vinblastine—TUBE1—lymph node—acquired immunodeficiency syndrome	0.000734	0.00651	CbGeAlD
Vinblastine—TUBB3—nervous system—acquired immunodeficiency syndrome	0.000723	0.00642	CbGeAlD
Vinblastine—TUBB4A—skin of body—acquired immunodeficiency syndrome	0.000711	0.00631	CbGeAlD
Vinblastine—TUBB1—nervous system—acquired immunodeficiency syndrome	0.000707	0.00627	CbGeAlD
Vinblastine—ABCB11—digestive system—acquired immunodeficiency syndrome	0.000706	0.00626	CbGeAlD
Vinblastine—TUBB3—central nervous system—acquired immunodeficiency syndrome	0.000696	0.00618	CbGeAlD
Vinblastine—TUBB1—central nervous system—acquired immunodeficiency syndrome	0.000681	0.00604	CbGeAlD
Vinblastine—TUBG1—brain—acquired immunodeficiency syndrome	0.00068	0.00603	CbGeAlD
Vinblastine—TUBB4A—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.000675	0.0229	CbGpPWpGaD
Vinblastine—TUBA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000674	0.00598	CbGeAlD
Vinblastine—JUN—lymphoid tissue—acquired immunodeficiency syndrome	0.000667	0.00592	CbGeAlD
Vinblastine—TUBA1A—digestive system—acquired immunodeficiency syndrome	0.000666	0.00591	CbGeAlD
Vinblastine—NR5A1—brain—acquired immunodeficiency syndrome	0.000663	0.00588	CbGeAlD
Vinblastine—JUN—digestive system—acquired immunodeficiency syndrome	0.000659	0.00585	CbGeAlD
Vinblastine—ABCC6—lung—acquired immunodeficiency syndrome	0.000657	0.00583	CbGeAlD
Vinblastine—TUBB6—Zalcitabine—Didanosine—acquired immunodeficiency syndrome	0.000657	0.131	CbGdCrCtD
Vinblastine—TUBG1—lymph node—acquired immunodeficiency syndrome	0.000657	0.00583	CbGeAlD
Vinblastine—TUBB2A—skin of body—acquired immunodeficiency syndrome	0.000647	0.00574	CbGeAlD
Vinblastine—TUBB6—skin of body—acquired immunodeficiency syndrome	0.000638	0.00566	CbGeAlD
Vinblastine—TUBA1A—blood—acquired immunodeficiency syndrome	0.000634	0.00563	CbGeAlD
Vinblastine—TUBB4B—retina—acquired immunodeficiency syndrome	0.000632	0.00561	CbGeAlD
Vinblastine—JUN—blood—acquired immunodeficiency syndrome	0.000628	0.00557	CbGeAlD
Vinblastine—TUBB4B—Pathogenic Escherichia coli infection—ACTG1—acquired immunodeficiency syndrome	0.000617	0.0209	CbGpPWpGaD
Vinblastine—TUBA1A—bone marrow—acquired immunodeficiency syndrome	0.000614	0.00545	CbGeAlD
Vinblastine—TUBA1A—spinal cord—acquired immunodeficiency syndrome	0.000611	0.00542	CbGeAlD
Vinblastine—JUN—bone marrow—acquired immunodeficiency syndrome	0.000608	0.00539	CbGeAlD
Vinblastine—JUN—spinal cord—acquired immunodeficiency syndrome	0.000605	0.00537	CbGeAlD
Vinblastine—JUN—FAS pathway and Stress induction of HSP regulation—ACTG1—acquired immunodeficiency syndrome	0.000592	0.0201	CbGpPWpGaD
Vinblastine—TUBA1A—vagina—acquired immunodeficiency syndrome	0.000588	0.00522	CbGeAlD
Vinblastine—JUN—vagina—acquired immunodeficiency syndrome	0.000582	0.00517	CbGeAlD
Vinblastine—TUBB4A—lymphoid tissue—acquired immunodeficiency syndrome	0.000576	0.00511	CbGeAlD
Vinblastine—TUBB4A—digestive system—acquired immunodeficiency syndrome	0.000569	0.00505	CbGeAlD
Vinblastine—SLC22A2—digestive system—acquired immunodeficiency syndrome	0.000566	0.00503	CbGeAlD
Vinblastine—TUBA1A—lung—acquired immunodeficiency syndrome	0.000556	0.00493	CbGeAlD
Vinblastine—TUBB4B—skin of body—acquired immunodeficiency syndrome	0.000555	0.00492	CbGeAlD
Vinblastine—TUBB3—brain—acquired immunodeficiency syndrome	0.000553	0.0049	CbGeAlD
Vinblastine—JUN—lung—acquired immunodeficiency syndrome	0.000551	0.00489	CbGeAlD
Vinblastine—TUBB2B—digestive system—acquired immunodeficiency syndrome	0.00055	0.00488	CbGeAlD
Vinblastine—TUBB4A—blood—acquired immunodeficiency syndrome	0.000542	0.00481	CbGeAlD
Vinblastine—TUBB1—brain—acquired immunodeficiency syndrome	0.00054	0.0048	CbGeAlD
Vinblastine—TUBB4A—spinal cord—acquired immunodeficiency syndrome	0.000522	0.00463	CbGeAlD
Vinblastine—TUBB2A—digestive system—acquired immunodeficiency syndrome	0.000518	0.00459	CbGeAlD
Vinblastine—TUBB6—lymphoid tissue—acquired immunodeficiency syndrome	0.000517	0.00459	CbGeAlD
Vinblastine—TUBA1A—nervous system—acquired immunodeficiency syndrome	0.000515	0.00457	CbGeAlD
Vinblastine—TUBB6—digestive system—acquired immunodeficiency syndrome	0.000511	0.00453	CbGeAlD
Vinblastine—JUN—nervous system—acquired immunodeficiency syndrome	0.00051	0.00453	CbGeAlD
Vinblastine—TUBB2B—spinal cord—acquired immunodeficiency syndrome	0.000505	0.00448	CbGeAlD
Vinblastine—TUBA1A—central nervous system—acquired immunodeficiency syndrome	0.000496	0.0044	CbGeAlD
Vinblastine—TUBB—blood—acquired immunodeficiency syndrome	0.000496	0.0044	CbGeAlD
Vinblastine—TUBB2A—blood—acquired immunodeficiency syndrome	0.000493	0.00438	CbGeAlD
Vinblastine—JUN—central nervous system—acquired immunodeficiency syndrome	0.000491	0.00436	CbGeAlD
Vinblastine—TUBB6—blood—acquired immunodeficiency syndrome	0.000486	0.00432	CbGeAlD
Vinblastine—TUBB2B—vagina—acquired immunodeficiency syndrome	0.000486	0.00431	CbGeAlD
Vinblastine—TUBB—bone marrow—acquired immunodeficiency syndrome	0.00048	0.00426	CbGeAlD
Vinblastine—TUBB—spinal cord—acquired immunodeficiency syndrome	0.000478	0.00424	CbGeAlD
Vinblastine—TUBB2A—bone marrow—acquired immunodeficiency syndrome	0.000477	0.00423	CbGeAlD
Vinblastine—TUBB4A—lung—acquired immunodeficiency syndrome	0.000475	0.00422	CbGeAlD
Vinblastine—TUBB2A—spinal cord—acquired immunodeficiency syndrome	0.000475	0.00422	CbGeAlD
Vinblastine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000474	0.00421	CbGeAlD
Vinblastine—TUBB6—bone marrow—acquired immunodeficiency syndrome	0.000471	0.00418	CbGeAlD
Vinblastine—TUBB6—spinal cord—acquired immunodeficiency syndrome	0.000469	0.00416	CbGeAlD
Vinblastine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000467	0.00414	CbGeAlD
Vinblastine—TUBB—vagina—acquired immunodeficiency syndrome	0.00046	0.00408	CbGeAlD
Vinblastine—TUBB2B—lung—acquired immunodeficiency syndrome	0.000459	0.00408	CbGeAlD
Vinblastine—TUBB2A—vagina—acquired immunodeficiency syndrome	0.000457	0.00406	CbGeAlD
Vinblastine—TUBB6—vagina—acquired immunodeficiency syndrome	0.000451	0.004	CbGeAlD
Vinblastine—TUBB4B—lymphoid tissue—acquired immunodeficiency syndrome	0.000449	0.00399	CbGeAlD
Vinblastine—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.000444	0.00277	CcSEcCtD
Vinblastine—TUBB4B—digestive system—acquired immunodeficiency syndrome	0.000444	0.00394	CbGeAlD
Vinblastine—TUBB4A—nervous system—acquired immunodeficiency syndrome	0.00044	0.0039	CbGeAlD
Vinblastine—Ill-defined disorder—Zidovudine—acquired immunodeficiency syndrome	0.000439	0.00274	CcSEcCtD
Vinblastine—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.000439	0.00274	CcSEcCtD
Vinblastine—Pain—Didanosine—acquired immunodeficiency syndrome	0.000438	0.00273	CcSEcCtD
Vinblastine—Anaemia—Zidovudine—acquired immunodeficiency syndrome	0.000438	0.00273	CcSEcCtD
Vinblastine—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000437	0.00272	CcSEcCtD
Vinblastine—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.000435	0.00271	CcSEcCtD
Vinblastine—TUBB—lung—acquired immunodeficiency syndrome	0.000435	0.00386	CbGeAlD
Vinblastine—TUBB2A—lung—acquired immunodeficiency syndrome	0.000432	0.00384	CbGeAlD
Vinblastine—Depression—Lamivudine—acquired immunodeficiency syndrome	0.000431	0.00269	CcSEcCtD
Vinblastine—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000429	0.00267	CcSEcCtD
Vinblastine—Malaise—Zidovudine—acquired immunodeficiency syndrome	0.000427	0.00266	CcSEcCtD
Vinblastine—TUBB6—lung—acquired immunodeficiency syndrome	0.000426	0.00378	CbGeAlD
Vinblastine—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.000426	0.00265	CcSEcCtD
Vinblastine—TUBB2B—nervous system—acquired immunodeficiency syndrome	0.000425	0.00377	CbGeAlD
Vinblastine—JUN—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.000425	0.0144	CbGpPWpGaD
Vinblastine—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.000425	0.00265	CcSEcCtD
Vinblastine—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.000425	0.00265	CcSEcCtD
Vinblastine—Neuropathy peripheral—Lamivudine—acquired immunodeficiency syndrome	0.000424	0.00264	CcSEcCtD
Vinblastine—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000424	0.00264	CcSEcCtD
Vinblastine—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000424	0.00264	CcSEcCtD
Vinblastine—TUBB4A—central nervous system—acquired immunodeficiency syndrome	0.000424	0.00376	CbGeAlD
Vinblastine—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.000423	0.00264	CcSEcCtD
Vinblastine—TUBB4B—blood—acquired immunodeficiency syndrome	0.000423	0.00375	CbGeAlD
Vinblastine—Alopecia—Efavirenz—acquired immunodeficiency syndrome	0.000422	0.00263	CcSEcCtD
Vinblastine—Hypoaesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000421	0.00262	CcSEcCtD
Vinblastine—Pharyngitis—Ritonavir—acquired immunodeficiency syndrome	0.00042	0.00262	CcSEcCtD
Vinblastine—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.000419	0.00261	CcSEcCtD
Vinblastine—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.000418	0.0026	CcSEcCtD
Vinblastine—ABCB11—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000417	0.0141	CbGpPWpGaD
Vinblastine—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.000414	0.00258	CcSEcCtD
Vinblastine—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.00041	0.00256	CcSEcCtD
Vinblastine—TUBB2B—central nervous system—acquired immunodeficiency syndrome	0.000409	0.00363	CbGeAlD
Vinblastine—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.000409	0.00255	CcSEcCtD
Vinblastine—TUBB4B—bone marrow—acquired immunodeficiency syndrome	0.000409	0.00363	CbGeAlD
Vinblastine—Ill-defined disorder—Indinavir—acquired immunodeficiency syndrome	0.000409	0.00255	CcSEcCtD
Vinblastine—TUBB4B—spinal cord—acquired immunodeficiency syndrome	0.000407	0.00361	CbGeAlD
Vinblastine—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.000407	0.00254	CcSEcCtD
Vinblastine—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.000407	0.00254	CcSEcCtD
Vinblastine—Hypoaesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000405	0.00252	CcSEcCtD
Vinblastine—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000405	0.00252	CcSEcCtD
Vinblastine—Alopecia—Delavirdine—acquired immunodeficiency syndrome	0.000404	0.00252	CcSEcCtD
Vinblastine—Pharyngitis—Saquinavir—acquired immunodeficiency syndrome	0.000404	0.00252	CcSEcCtD
Vinblastine—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000404	0.00252	CcSEcCtD
Vinblastine—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000403	0.00251	CcSEcCtD
Vinblastine—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.000401	0.0025	CcSEcCtD
Vinblastine—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.0004	0.0025	CcSEcCtD
Vinblastine—TUBB2A—nervous system—acquired immunodeficiency syndrome	0.0004	0.00355	CbGeAlD
Vinblastine—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.000399	0.00249	CcSEcCtD
Vinblastine—Discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000398	0.00248	CcSEcCtD
Vinblastine—Malaise—Indinavir—acquired immunodeficiency syndrome	0.000397	0.00248	CcSEcCtD
Vinblastine—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000396	0.00247	CcSEcCtD
Vinblastine—TUBB6—nervous system—acquired immunodeficiency syndrome	0.000395	0.0035	CbGeAlD
Vinblastine—Pain—Nevirapine—acquired immunodeficiency syndrome	0.000394	0.00245	CcSEcCtD
Vinblastine—TUBA1A—brain—acquired immunodeficiency syndrome	0.000394	0.00349	CbGeAlD
Vinblastine—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.000393	0.00245	CcSEcCtD
Vinblastine—TUBB4B—vagina—acquired immunodeficiency syndrome	0.000392	0.00348	CbGeAlD
Vinblastine—JUN—brain—acquired immunodeficiency syndrome	0.00039	0.00346	CbGeAlD
Vinblastine—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000388	0.00242	CcSEcCtD
Vinblastine—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000387	0.00241	CcSEcCtD
Vinblastine—Hypoaesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000386	0.00241	CcSEcCtD
Vinblastine—Ill-defined disorder—Efavirenz—acquired immunodeficiency syndrome	0.000386	0.00241	CcSEcCtD
Vinblastine—Pharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.000385	0.0024	CcSEcCtD
Vinblastine—TUBB2A—central nervous system—acquired immunodeficiency syndrome	0.000385	0.00342	CbGeAlD
Vinblastine—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000385	0.0024	CcSEcCtD
Vinblastine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000384	0.0024	CcSEcCtD
Vinblastine—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.000381	0.00238	CcSEcCtD
Vinblastine—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000381	0.00237	CcSEcCtD
Vinblastine—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00038	0.00237	CcSEcCtD
Vinblastine—Pain—Stavudine—acquired immunodeficiency syndrome	0.00038	0.00237	CcSEcCtD
Vinblastine—TUBA1A—lymph node—acquired immunodeficiency syndrome	0.00038	0.00337	CbGeAlD
Vinblastine—TUBB6—central nervous system—acquired immunodeficiency syndrome	0.00038	0.00337	CbGeAlD
Vinblastine—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00038	0.00237	CcSEcCtD
Vinblastine—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000378	0.00236	CcSEcCtD
Vinblastine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000377	0.00235	CcSEcCtD
Vinblastine—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000377	0.00235	CcSEcCtD
Vinblastine—JUN—lymph node—acquired immunodeficiency syndrome	0.000377	0.00334	CbGeAlD
Vinblastine—Malaise—Efavirenz—acquired immunodeficiency syndrome	0.000375	0.00234	CcSEcCtD
Vinblastine—Pain—Abacavir—acquired immunodeficiency syndrome	0.000375	0.00233	CcSEcCtD
Vinblastine—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000374	0.00233	CcSEcCtD
Vinblastine—TUBB4B—lung—acquired immunodeficiency syndrome	0.000371	0.00329	CbGeAlD
Vinblastine—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.000371	0.00231	CcSEcCtD
Vinblastine—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.000369	0.0023	CcSEcCtD
Vinblastine—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000368	0.0023	CcSEcCtD
Vinblastine—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000368	0.00229	CcSEcCtD
Vinblastine—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000368	0.00229	CcSEcCtD
Vinblastine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000368	0.00229	CcSEcCtD
Vinblastine—JUN—Calcium signaling in the CD4+ TCR pathway—CD40LG—acquired immunodeficiency syndrome	0.000366	0.0124	CbGpPWpGaD
Vinblastine—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000365	0.00227	CcSEcCtD
Vinblastine—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000364	0.00227	CcSEcCtD
Vinblastine—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000364	0.00227	CcSEcCtD
Vinblastine—JUN—Calcium signaling in the CD4+ TCR pathway—CSF2—acquired immunodeficiency syndrome	0.000362	0.0123	CbGpPWpGaD
Vinblastine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000361	0.00225	CcSEcCtD
Vinblastine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000361	0.00225	CcSEcCtD
Vinblastine—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.00036	0.00224	CcSEcCtD
Vinblastine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000359	0.00224	CcSEcCtD
Vinblastine—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.000359	0.00224	CcSEcCtD
Vinblastine—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000359	0.00318	CbGeAlD
Vinblastine—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000358	0.00223	CcSEcCtD
Vinblastine—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000358	0.00223	CcSEcCtD
Vinblastine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000357	0.00223	CcSEcCtD
Vinblastine—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000356	0.00222	CcSEcCtD
Vinblastine—JUN—Calcium signaling in the CD4+ TCR pathway—IL4—acquired immunodeficiency syndrome	0.000356	0.0121	CbGpPWpGaD
Vinblastine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000353	0.0022	CcSEcCtD
Vinblastine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000352	0.00219	CcSEcCtD
Vinblastine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000352	0.00219	CcSEcCtD
Vinblastine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000352	0.00219	CcSEcCtD
Vinblastine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00035	0.00218	CcSEcCtD
Vinblastine—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00035	0.00218	CcSEcCtD
Vinblastine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000347	0.00216	CcSEcCtD
Vinblastine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000346	0.00216	CcSEcCtD
Vinblastine—TUBB6—Zalcitabine—Lamivudine—acquired immunodeficiency syndrome	0.000345	0.0686	CbGdCrCtD
Vinblastine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000344	0.00214	CcSEcCtD
Vinblastine—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000343	0.00214	CcSEcCtD
Vinblastine—TUBB4B—nervous system—acquired immunodeficiency syndrome	0.000343	0.00305	CbGeAlD
Vinblastine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000343	0.00214	CcSEcCtD
Vinblastine—TUBA1A—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000342	0.0116	CbGpPWpGaD
Vinblastine—ABCC2—blood—acquired immunodeficiency syndrome	0.000342	0.00303	CbGeAlD
Vinblastine—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000342	0.00213	CcSEcCtD
Vinblastine—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.00034	0.00212	CcSEcCtD
Vinblastine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000339	0.00211	CcSEcCtD
Vinblastine—TUBB4A—brain—acquired immunodeficiency syndrome	0.000336	0.00298	CbGeAlD
Vinblastine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000336	0.00209	CcSEcCtD
Vinblastine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000336	0.00298	CbGeAlD
Vinblastine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000335	0.00209	CcSEcCtD
Vinblastine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000334	0.00208	CcSEcCtD
Vinblastine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000333	0.00207	CcSEcCtD
Vinblastine—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000332	0.00207	CcSEcCtD
Vinblastine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000331	0.00206	CcSEcCtD
Vinblastine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000331	0.00206	CcSEcCtD
Vinblastine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000331	0.00206	CcSEcCtD
Vinblastine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00033	0.00206	CcSEcCtD
Vinblastine—TUBB4B—central nervous system—acquired immunodeficiency syndrome	0.00033	0.00293	CbGeAlD
Vinblastine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00033	0.00205	CcSEcCtD
Vinblastine—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000329	0.00205	CcSEcCtD
Vinblastine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000329	0.00205	CcSEcCtD
Vinblastine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000328	0.00204	CcSEcCtD
Vinblastine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000328	0.00204	CcSEcCtD
Vinblastine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000326	0.00203	CcSEcCtD
Vinblastine—TUBB2B—brain—acquired immunodeficiency syndrome	0.000325	0.00288	CbGeAlD
Vinblastine—TUBB4A—lymph node—acquired immunodeficiency syndrome	0.000325	0.00288	CbGeAlD
Vinblastine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000324	0.00202	CcSEcCtD
Vinblastine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000323	0.00201	CcSEcCtD
Vinblastine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000323	0.00201	CcSEcCtD
Vinblastine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000321	0.002	CcSEcCtD
Vinblastine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00032	0.00199	CcSEcCtD
Vinblastine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.00032	0.00199	CcSEcCtD
Vinblastine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000319	0.00199	CcSEcCtD
Vinblastine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000319	0.00199	CcSEcCtD
Vinblastine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000319	0.00199	CcSEcCtD
Vinblastine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000318	0.00198	CcSEcCtD
Vinblastine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000318	0.00198	CcSEcCtD
Vinblastine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000318	0.00198	CcSEcCtD
Vinblastine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000317	0.00198	CcSEcCtD
Vinblastine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000316	0.00197	CcSEcCtD
Vinblastine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000315	0.00196	CcSEcCtD
Vinblastine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000314	0.00196	CcSEcCtD
Vinblastine—TUBB2B—lymph node—acquired immunodeficiency syndrome	0.000314	0.00279	CbGeAlD
Vinblastine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000314	0.00195	CcSEcCtD
Vinblastine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000313	0.00195	CcSEcCtD
Vinblastine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000313	0.00195	CcSEcCtD
Vinblastine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00031	0.00193	CcSEcCtD
Vinblastine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00031	0.00193	CcSEcCtD
Vinblastine—NR5A1—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	0.000308	0.0105	CbGpPWpGaD
Vinblastine—JUN—CD40/CD40L signaling—CD40LG—acquired immunodeficiency syndrome	0.000308	0.0104	CbGpPWpGaD
Vinblastine—TUBB—brain—acquired immunodeficiency syndrome	0.000308	0.00273	CbGeAlD
Vinblastine—Pain—Indinavir—acquired immunodeficiency syndrome	0.000307	0.00192	CcSEcCtD
Vinblastine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000307	0.00192	CcSEcCtD
Vinblastine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000307	0.00191	CcSEcCtD
Vinblastine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000306	0.00191	CcSEcCtD
Vinblastine—TUBB2A—brain—acquired immunodeficiency syndrome	0.000306	0.00272	CbGeAlD
Vinblastine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000306	0.0019	CcSEcCtD
Vinblastine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000305	0.0019	CcSEcCtD
Vinblastine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000305	0.0019	CcSEcCtD
Vinblastine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000305	0.0019	CcSEcCtD
Vinblastine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000304	0.0019	CcSEcCtD
Vinblastine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000304	0.0019	CcSEcCtD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—CCL4—acquired immunodeficiency syndrome	0.000304	0.0103	CbGpPWpGaD
Vinblastine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000304	0.00189	CcSEcCtD
Vinblastine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000303	0.00189	CcSEcCtD
Vinblastine—TUBB6—brain—acquired immunodeficiency syndrome	0.000302	0.00268	CbGeAlD
Vinblastine—ABCC1—blood—acquired immunodeficiency syndrome	0.000301	0.00267	CbGeAlD
Vinblastine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.0003	0.00187	CcSEcCtD
Vinblastine—JUN—CD40/CD40L signaling—IL4—acquired immunodeficiency syndrome	0.000299	0.0101	CbGpPWpGaD
Vinblastine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000298	0.00186	CcSEcCtD
Vinblastine—TUBB—lymph node—acquired immunodeficiency syndrome	0.000297	0.00264	CbGeAlD
Vinblastine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000296	0.00185	CcSEcCtD
Vinblastine—TUBB2A—lymph node—acquired immunodeficiency syndrome	0.000296	0.00262	CbGeAlD
Vinblastine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000295	0.00184	CcSEcCtD
Vinblastine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000295	0.00184	CcSEcCtD
Vinblastine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000294	0.00183	CcSEcCtD
Vinblastine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000294	0.00183	CcSEcCtD
Vinblastine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000294	0.00183	CcSEcCtD
Vinblastine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000293	0.00183	CcSEcCtD
Vinblastine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000293	0.00183	CcSEcCtD
Vinblastine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.00182	CcSEcCtD
Vinblastine—TUBB6—lymph node—acquired immunodeficiency syndrome	0.000292	0.00259	CbGeAlD
Vinblastine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00029	0.00181	CcSEcCtD
Vinblastine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00029	0.00181	CcSEcCtD
Vinblastine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00029	0.00181	CcSEcCtD
Vinblastine—JUN—Integrated Breast Cancer Pathway—APOBEC3G—acquired immunodeficiency syndrome	0.000289	0.00979	CbGpPWpGaD
Vinblastine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000289	0.0018	CcSEcCtD
Vinblastine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000286	0.00179	CcSEcCtD
Vinblastine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000284	0.00177	CcSEcCtD
Vinblastine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000284	0.00177	CcSEcCtD
Vinblastine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000284	0.00177	CcSEcCtD
Vinblastine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000283	0.00176	CcSEcCtD
Vinblastine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000283	0.00176	CcSEcCtD
Vinblastine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000283	0.00176	CcSEcCtD
Vinblastine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00028	0.00174	CcSEcCtD
Vinblastine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000279	0.00174	CcSEcCtD
Vinblastine—ABCC1—vagina—acquired immunodeficiency syndrome	0.000279	0.00248	CbGeAlD
Vinblastine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000279	0.00174	CcSEcCtD
Vinblastine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000279	0.00174	CcSEcCtD
Vinblastine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000278	0.00173	CcSEcCtD
Vinblastine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000278	0.00173	CcSEcCtD
Vinblastine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000278	0.00173	CcSEcCtD
Vinblastine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000277	0.00173	CcSEcCtD
Vinblastine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000276	0.00172	CcSEcCtD
Vinblastine—TUBB6—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000275	0.00933	CbGpPWpGaD
Vinblastine—TUBB2B—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000275	0.00933	CbGpPWpGaD
Vinblastine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000274	0.00171	CcSEcCtD
Vinblastine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000274	0.00171	CcSEcCtD
Vinblastine—JUN—TWEAK Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.000273	0.00926	CbGpPWpGaD
Vinblastine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00027	0.00168	CcSEcCtD
Vinblastine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00168	CcSEcCtD
Vinblastine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000269	0.00167	CcSEcCtD
Vinblastine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000268	0.00167	CcSEcCtD
Vinblastine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000266	0.00166	CcSEcCtD
Vinblastine—TUBB3—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000266	0.00901	CbGpPWpGaD
Vinblastine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000265	0.00165	CcSEcCtD
Vinblastine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000265	0.00165	CcSEcCtD
Vinblastine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000264	0.00165	CcSEcCtD
Vinblastine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000264	0.00165	CcSEcCtD
Vinblastine—ABCC1—lung—acquired immunodeficiency syndrome	0.000264	0.00234	CbGeAlD
Vinblastine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000263	0.00164	CcSEcCtD
Vinblastine—TUBB4B—brain—acquired immunodeficiency syndrome	0.000262	0.00233	CbGeAlD
Vinblastine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000261	0.00163	CcSEcCtD
Vinblastine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00026	0.00162	CcSEcCtD
Vinblastine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.00162	CcSEcCtD
Vinblastine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000258	0.00161	CcSEcCtD
Vinblastine—TUBB2A—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000257	0.00872	CbGpPWpGaD
Vinblastine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.0016	CcSEcCtD
Vinblastine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.0016	CcSEcCtD
Vinblastine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000257	0.0016	CcSEcCtD
Vinblastine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000256	0.00159	CcSEcCtD
Vinblastine—TUBB4B—lymph node—acquired immunodeficiency syndrome	0.000253	0.00225	CbGeAlD
Vinblastine—NR5A1—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000252	0.00854	CbGpPWpGaD
Vinblastine—TUBB1—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000252	0.00853	CbGpPWpGaD
Vinblastine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.00157	CcSEcCtD
Vinblastine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00025	0.00156	CcSEcCtD
Vinblastine—JUN—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	0.00025	0.00848	CbGpPWpGaD
Vinblastine—JUN—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.00025	0.00848	CbGpPWpGaD
Vinblastine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.00154	CcSEcCtD
Vinblastine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000248	0.00154	CcSEcCtD
Vinblastine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000247	0.00154	CcSEcCtD
Vinblastine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000247	0.00154	CcSEcCtD
Vinblastine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000246	0.00153	CcSEcCtD
Vinblastine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000246	0.00153	CcSEcCtD
Vinblastine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000246	0.00153	CcSEcCtD
Vinblastine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000244	0.00152	CcSEcCtD
Vinblastine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000242	0.00151	CcSEcCtD
Vinblastine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.00024	0.00149	CcSEcCtD
Vinblastine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000239	0.00149	CcSEcCtD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—IFNA1—acquired immunodeficiency syndrome	0.000239	0.00812	CbGpPWpGaD
Vinblastine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.00149	CcSEcCtD
Vinblastine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000238	0.00148	CcSEcCtD
Vinblastine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.00148	CcSEcCtD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—CCL4—acquired immunodeficiency syndrome	0.000237	0.00804	CbGpPWpGaD
Vinblastine—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—acquired immunodeficiency syndrome	0.000237	0.00802	CbGpPWpGaD
Vinblastine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.00147	CcSEcCtD
Vinblastine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.00147	CcSEcCtD
Vinblastine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.00147	CcSEcCtD
Vinblastine—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—acquired immunodeficiency syndrome	0.000234	0.00793	CbGpPWpGaD
Vinblastine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000233	0.00145	CcSEcCtD
Vinblastine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.00145	CcSEcCtD
Vinblastine—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—acquired immunodeficiency syndrome	0.00023	0.0078	CbGpPWpGaD
Vinblastine—JUN—BCR signaling pathway—CD79A—acquired immunodeficiency syndrome	0.00023	0.00779	CbGpPWpGaD
Vinblastine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00023	0.00143	CcSEcCtD
Vinblastine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.00142	CcSEcCtD
Vinblastine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000229	0.00142	CcSEcCtD
Vinblastine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.00142	CcSEcCtD
Vinblastine—TUBB4A—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000226	0.00766	CbGpPWpGaD
Vinblastine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.00141	CcSEcCtD
Vinblastine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000225	0.0014	CcSEcCtD
Vinblastine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000225	0.0014	CcSEcCtD
Vinblastine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.00139	CcSEcCtD
Vinblastine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.00138	CcSEcCtD
Vinblastine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.00136	CcSEcCtD
Vinblastine—ABCB11—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.000218	0.00739	CbGpPWpGaD
Vinblastine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000216	0.00135	CcSEcCtD
Vinblastine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.00134	CcSEcCtD
Vinblastine—JUN—Calcium signaling in the CD4+ TCR pathway—IFNG—acquired immunodeficiency syndrome	0.000215	0.00729	CbGpPWpGaD
Vinblastine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000215	0.00134	CcSEcCtD
Vinblastine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000214	0.00133	CcSEcCtD
Vinblastine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.00133	CcSEcCtD
Vinblastine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000213	0.00133	CcSEcCtD
Vinblastine—JUN—IL12 signaling mediated by STAT4—IFNG—acquired immunodeficiency syndrome	0.000209	0.0071	CbGpPWpGaD
Vinblastine—JUN—Myometrial Relaxation and Contraction Pathways—ACTG1—acquired immunodeficiency syndrome	0.000208	0.00707	CbGpPWpGaD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—CCL3—acquired immunodeficiency syndrome	0.000208	0.00704	CbGpPWpGaD
Vinblastine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.00129	CcSEcCtD
Vinblastine—TUBB4B—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000207	0.00701	CbGpPWpGaD
Vinblastine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.00129	CcSEcCtD
Vinblastine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.00128	CcSEcCtD
Vinblastine—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000205	0.00182	CbGeAlD
Vinblastine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000204	0.00127	CcSEcCtD
Vinblastine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.00127	CcSEcCtD
Vinblastine—JUN—Senescence and Autophagy in Cancer—CCL3—acquired immunodeficiency syndrome	0.000203	0.00688	CbGpPWpGaD
Vinblastine—JUN—IL12 signaling mediated by STAT4—CD4—acquired immunodeficiency syndrome	0.000202	0.00686	CbGpPWpGaD
Vinblastine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.00126	CcSEcCtD
Vinblastine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.00124	CcSEcCtD
Vinblastine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.00123	CcSEcCtD
Vinblastine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.00123	CcSEcCtD
Vinblastine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.0012	CcSEcCtD
Vinblastine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.00119	CcSEcCtD
Vinblastine—JUN—Calcium signaling in the CD4+ TCR pathway—IL2—acquired immunodeficiency syndrome	0.000191	0.00648	CbGpPWpGaD
Vinblastine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.00119	CcSEcCtD
Vinblastine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.00118	CcSEcCtD
Vinblastine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.00117	CcSEcCtD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—CD8A—acquired immunodeficiency syndrome	0.000187	0.00635	CbGpPWpGaD
Vinblastine—JUN—Regulation of retinoblastoma protein—CSF2—acquired immunodeficiency syndrome	0.000187	0.00635	CbGpPWpGaD
Vinblastine—ABCC1—brain—acquired immunodeficiency syndrome	0.000187	0.00166	CbGeAlD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—MBL2—acquired immunodeficiency syndrome	0.000187	0.00634	CbGpPWpGaD
Vinblastine—JUN—IL12 signaling mediated by STAT4—IL2—acquired immunodeficiency syndrome	0.000186	0.00631	CbGpPWpGaD
Vinblastine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.00115	CcSEcCtD
Vinblastine—ABCB1—retina—acquired immunodeficiency syndrome	0.000184	0.00163	CbGeAlD
Vinblastine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.00114	CcSEcCtD
Vinblastine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000182	0.00162	CbGeAlD
Vinblastine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.00113	CcSEcCtD
Vinblastine—JUN—AP-1 transcription factor network—IL10—acquired immunodeficiency syndrome	0.000181	0.00613	CbGpPWpGaD
Vinblastine—ABCC1—lymph node—acquired immunodeficiency syndrome	0.000181	0.0016	CbGeAlD
Vinblastine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000179	0.00159	CbGeAlD
Vinblastine—JUN—AP-1 transcription factor network—CSF2—acquired immunodeficiency syndrome	0.000179	0.00606	CbGpPWpGaD
Vinblastine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.00111	CcSEcCtD
Vinblastine—JUN—Focal Adhesion—ACTG1—acquired immunodeficiency syndrome	0.000177	0.006	CbGpPWpGaD
Vinblastine—JUN—AP-1 transcription factor network—IL4—acquired immunodeficiency syndrome	0.000176	0.00596	CbGpPWpGaD
Vinblastine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.00109	CcSEcCtD
Vinblastine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000174	0.00154	CbGeAlD
Vinblastine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.00108	CcSEcCtD
Vinblastine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.00107	CcSEcCtD
Vinblastine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000171	0.00152	CbGeAlD
Vinblastine—JUN—B Cell Receptor Signaling Pathway—CD79A—acquired immunodeficiency syndrome	0.000171	0.00579	CbGpPWpGaD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—IFNA1—acquired immunodeficiency syndrome	0.000169	0.00573	CbGpPWpGaD
Vinblastine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.00102	CcSEcCtD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—CCL3—acquired immunodeficiency syndrome	0.000162	0.00549	CbGpPWpGaD
Vinblastine—JUN—Regulation of nuclear SMAD2/3 signaling—IL10—acquired immunodeficiency syndrome	0.000161	0.00545	CbGpPWpGaD
Vinblastine—JUN—Glucocorticoid receptor regulatory network—CSF2—acquired immunodeficiency syndrome	0.000157	0.00534	CbGpPWpGaD
Vinblastine—JUN—Glucocorticoid receptor regulatory network—IL4—acquired immunodeficiency syndrome	0.000155	0.00525	CbGpPWpGaD
Vinblastine—JUN—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000149	0.00504	CbGpPWpGaD
Vinblastine—NR5A1—Gene Expression—CCNT1—acquired immunodeficiency syndrome	0.000149	0.00504	CbGpPWpGaD
Vinblastine—JUN—IL-5 Signaling Pathway—IL2—acquired immunodeficiency syndrome	0.000148	0.00501	CbGpPWpGaD
Vinblastine—JUN—TCR Signaling Pathway—CD8A—acquired immunodeficiency syndrome	0.000146	0.00496	CbGpPWpGaD
Vinblastine—JUN—IL-2 Signaling Pathway—IL2—acquired immunodeficiency syndrome	0.000142	0.00482	CbGpPWpGaD
Vinblastine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000141	0.00125	CbGeAlD
Vinblastine—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	0.000139	0.00472	CbGpPWpGaD
Vinblastine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000139	0.00123	CbGeAlD
Vinblastine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000136	0.0012	CbGeAlD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.000134	0.00455	CbGpPWpGaD
Vinblastine—JUN—TCR Signaling Pathway—CCR5—acquired immunodeficiency syndrome	0.000134	0.00453	CbGpPWpGaD
Vinblastine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000134	0.00119	CbGeAlD
Vinblastine—JUN—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.000132	0.00448	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—IFNA1—acquired immunodeficiency syndrome	0.000132	0.00447	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Receptor Signaling—IFNG—acquired immunodeficiency syndrome	0.000131	0.00444	CbGpPWpGaD
Vinblastine—JUN—IL2-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.000131	0.00444	CbGpPWpGaD
Vinblastine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000131	0.00116	CbGeAlD
Vinblastine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000129	0.00115	CbGeAlD
Vinblastine—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	0.000124	0.00419	CbGpPWpGaD
Vinblastine—ABCB1—blood—acquired immunodeficiency syndrome	0.000123	0.00109	CbGeAlD
Vinblastine—JUN—ATF-2 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.000122	0.00413	CbGpPWpGaD
Vinblastine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000119	0.00106	CbGeAlD
Vinblastine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000118	0.00105	CbGeAlD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000117	0.00396	CbGpPWpGaD
Vinblastine—JUN—IL2-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.000116	0.00394	CbGpPWpGaD
Vinblastine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000114	0.00101	CbGeAlD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—IFNG—acquired immunodeficiency syndrome	0.000111	0.00378	CbGpPWpGaD
Vinblastine—JUN—Regulation of Telomerase—IFNG—acquired immunodeficiency syndrome	0.000109	0.00369	CbGpPWpGaD
Vinblastine—ABCB1—lung—acquired immunodeficiency syndrome	0.000108	0.000957	CbGeAlD
Vinblastine—JUN—AP-1 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.000106	0.0036	CbGpPWpGaD
Vinblastine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000106	0.000941	CbGeAlD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.000105	0.00355	CbGpPWpGaD
Vinblastine—JUN—FAS pathway and Stress induction of HSP regulation—TNF—acquired immunodeficiency syndrome	0.000104	0.00351	CbGpPWpGaD
Vinblastine—JUN—TWEAK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000104	0.00351	CbGpPWpGaD
Vinblastine—ABCB1—nervous system—acquired immunodeficiency syndrome	9.98e-05	0.000886	CbGeAlD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—IL2—acquired immunodeficiency syndrome	9.9e-05	0.00336	CbGpPWpGaD
Vinblastine—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	9.82e-05	0.00333	CbGpPWpGaD
Vinblastine—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	9.82e-05	0.00333	CbGpPWpGaD
Vinblastine—JUN—Regulation of Telomerase—IL2—acquired immunodeficiency syndrome	9.67e-05	0.00328	CbGpPWpGaD
Vinblastine—JUN—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	9.63e-05	0.00326	CbGpPWpGaD
Vinblastine—ABCB1—central nervous system—acquired immunodeficiency syndrome	9.61e-05	0.000853	CbGeAlD
Vinblastine—JUN—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	9.52e-05	0.00323	CbGpPWpGaD
Vinblastine—JUN—AP-1 transcription factor network—IL2—acquired immunodeficiency syndrome	9.45e-05	0.0032	CbGpPWpGaD
Vinblastine—JUN—Glucocorticoid receptor regulatory network—IFNG—acquired immunodeficiency syndrome	9.37e-05	0.00318	CbGpPWpGaD
Vinblastine—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—acquired immunodeficiency syndrome	9.25e-05	0.00313	CbGpPWpGaD
Vinblastine—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	9e-05	0.00305	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	8.77e-05	0.00297	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	8.51e-05	0.00288	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Receptor Signaling—TNF—acquired immunodeficiency syndrome	8.47e-05	0.00287	CbGpPWpGaD
Vinblastine—JUN—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	8.4e-05	0.00285	CbGpPWpGaD
Vinblastine—JUN—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	8.35e-05	0.00283	CbGpPWpGaD
Vinblastine—JUN—Glucocorticoid receptor regulatory network—IL2—acquired immunodeficiency syndrome	8.32e-05	0.00282	CbGpPWpGaD
Vinblastine—JUN—FCERI mediated MAPK activation—IL6—acquired immunodeficiency syndrome	8.2e-05	0.00278	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—IFNG—acquired immunodeficiency syndrome	7.68e-05	0.00261	CbGpPWpGaD
Vinblastine—JUN—IL6-mediated signaling events—IL6—acquired immunodeficiency syndrome	7.64e-05	0.00259	CbGpPWpGaD
Vinblastine—ABCB1—brain—acquired immunodeficiency syndrome	7.63e-05	0.000677	CbGeAlD
Vinblastine—ABCB1—lymph node—acquired immunodeficiency syndrome	7.37e-05	0.000654	CbGeAlD
Vinblastine—JUN—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	7.28e-05	0.00247	CbGpPWpGaD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—TNF—acquired immunodeficiency syndrome	7.21e-05	0.00245	CbGpPWpGaD
Vinblastine—JUN—MAP kinase activation in TLR cascade—IL6—acquired immunodeficiency syndrome	6.64e-05	0.00225	CbGpPWpGaD
Vinblastine—ABCC6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.45e-05	0.00219	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	6.45e-05	0.00219	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	6.45e-05	0.00219	CbGpPWpGaD
Vinblastine—JUN—ATF-2 transcription factor network—IL6—acquired immunodeficiency syndrome	6.37e-05	0.00216	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	6.27e-05	0.00213	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	6.13e-05	0.00208	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—TAT—acquired immunodeficiency syndrome	6.12e-05	0.00207	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—MBL2—acquired immunodeficiency syndrome	5.98e-05	0.00203	CbGpPWpGaD
Vinblastine—JUN—Apoptosis—TNF—acquired immunodeficiency syndrome	5.95e-05	0.00202	CbGpPWpGaD
Vinblastine—JUN—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	5.55e-05	0.00188	CbGpPWpGaD
Vinblastine—JUN—TNF alpha Signaling Pathway—TNF—acquired immunodeficiency syndrome	5.53e-05	0.00187	CbGpPWpGaD
Vinblastine—JUN—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—acquired immunodeficiency syndrome	5.25e-05	0.00178	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	5.22e-05	0.00177	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—AGPS—acquired immunodeficiency syndrome	5.2e-05	0.00176	CbGpPWpGaD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	5.09e-05	0.00173	CbGpPWpGaD
Vinblastine—JUN—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	4.89e-05	0.00166	CbGpPWpGaD
Vinblastine—JUN—MyD88 cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	4.75e-05	0.00161	CbGpPWpGaD
Vinblastine—JUN—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—acquired immunodeficiency syndrome	4.71e-05	0.0016	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—CCR2—acquired immunodeficiency syndrome	4.69e-05	0.00159	CbGpPWpGaD
Vinblastine—JUN—MyD88 dependent cascade initiated on endosome—IL6—acquired immunodeficiency syndrome	4.62e-05	0.00157	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—TAT—acquired immunodeficiency syndrome	4.59e-05	0.00156	CbGpPWpGaD
Vinblastine—JUN—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	4.54e-05	0.00154	CbGpPWpGaD
Vinblastine—JUN—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	4.46e-05	0.00151	CbGpPWpGaD
Vinblastine—JUN—Toll Like Receptor 9 (TLR9) Cascade—IL6—acquired immunodeficiency syndrome	4.46e-05	0.00151	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—TNF—acquired immunodeficiency syndrome	4.4e-05	0.00149	CbGpPWpGaD
Vinblastine—ABCC1—Disease—APOBEC3G—acquired immunodeficiency syndrome	4.39e-05	0.00149	CbGpPWpGaD
Vinblastine—JUN—MyD88:Mal cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	4.39e-05	0.00149	CbGpPWpGaD
Vinblastine—JUN—Immune System—ACTG1—acquired immunodeficiency syndrome	4.24e-05	0.00144	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	4.23e-05	0.00143	CbGpPWpGaD
Vinblastine—JUN—MyD88-independent cascade—IL6—acquired immunodeficiency syndrome	4.21e-05	0.00143	CbGpPWpGaD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	4.11e-05	0.00139	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—IL6—acquired immunodeficiency syndrome	4.01e-05	0.00136	CbGpPWpGaD
Vinblastine—JUN—Senescence-Associated Secretory Phenotype (SASP)—IL6—acquired immunodeficiency syndrome	4.01e-05	0.00136	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—TAT—acquired immunodeficiency syndrome	4e-05	0.00136	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	3.97e-05	0.00135	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.91e-05	0.00132	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	3.79e-05	0.00129	CbGpPWpGaD
Vinblastine—JUN—Activated TLR4 signalling—IL6—acquired immunodeficiency syndrome	3.78e-05	0.00128	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CCNT1—acquired immunodeficiency syndrome	3.73e-05	0.00126	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	3.62e-05	0.00123	CbGpPWpGaD
Vinblastine—TUBB6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.57e-05	0.00121	CbGpPWpGaD
Vinblastine—TUBB2B—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.57e-05	0.00121	CbGpPWpGaD
Vinblastine—JUN—Toll Like Receptor 4 (TLR4) Cascade—IL6—acquired immunodeficiency syndrome	3.56e-05	0.00121	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—IL6—acquired immunodeficiency syndrome	3.55e-05	0.0012	CbGpPWpGaD
Vinblastine—JUN—Immune System—MBL2—acquired immunodeficiency syndrome	3.49e-05	0.00118	CbGpPWpGaD
Vinblastine—TUBB3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.44e-05	0.00117	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	3.42e-05	0.00116	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—AGPS—acquired immunodeficiency syndrome	3.4e-05	0.00115	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	3.37e-05	0.00114	CbGpPWpGaD
Vinblastine—TUBB2A—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.34e-05	0.00113	CbGpPWpGaD
Vinblastine—TUBB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.26e-05	0.00111	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	3.21e-05	0.00109	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	3.18e-05	0.00108	CbGpPWpGaD
Vinblastine—JUN—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	3.17e-05	0.00108	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.16e-05	0.00107	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.16e-05	0.00107	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	3.08e-05	0.00104	CbGpPWpGaD
Vinblastine—JUN—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	2.94e-05	0.000997	CbGpPWpGaD
Vinblastine—SLC22A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.93e-05	0.000994	CbGpPWpGaD
Vinblastine—TUBB4A—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.93e-05	0.000993	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.92e-05	0.000991	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.86e-05	0.00097	CbGpPWpGaD
Vinblastine—JUN—Immune System—CCR2—acquired immunodeficiency syndrome	2.73e-05	0.000927	CbGpPWpGaD
Vinblastine—TUBB4B—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.68e-05	0.000908	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	2.64e-05	0.000896	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—IL6—acquired immunodeficiency syndrome	2.54e-05	0.000861	CbGpPWpGaD
Vinblastine—JUN—Immune System—IFNA1—acquired immunodeficiency syndrome	2.46e-05	0.000834	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	2.45e-05	0.000832	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.4e-05	0.000812	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD79A—acquired immunodeficiency syndrome	2.39e-05	0.00081	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.39e-05	0.00081	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	2.19e-05	0.000741	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	2.06e-05	0.000698	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CXCR4—acquired immunodeficiency syndrome	1.96e-05	0.000664	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.95e-05	0.000663	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD40LG—acquired immunodeficiency syndrome	1.95e-05	0.00066	CbGpPWpGaD
Vinblastine—JUN—Immune System—CSF2—acquired immunodeficiency syndrome	1.93e-05	0.000653	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD8A—acquired immunodeficiency syndrome	1.93e-05	0.000653	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	1.92e-05	0.000651	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.9e-05	0.000644	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.86e-05	0.00063	CbGpPWpGaD
Vinblastine—JUN—Immune System—HLA-B—acquired immunodeficiency syndrome	1.85e-05	0.000628	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.8e-05	0.00061	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.77e-05	0.000599	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.75e-05	0.000594	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.73e-05	0.000587	CbGpPWpGaD
Vinblastine—ABCC1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.71e-05	0.00058	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.66e-05	0.000563	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.66e-05	0.000563	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.49e-05	0.000505	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.35e-05	0.000457	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CCR5—acquired immunodeficiency syndrome	1.34e-05	0.000455	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.26e-05	0.000429	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.25e-05	0.000422	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.21e-05	0.00041	CbGpPWpGaD
Vinblastine—JUN—Immune System—IFNG—acquired immunodeficiency syndrome	1.15e-05	0.000388	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.15e-05	0.000388	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.14e-05	0.000386	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD4—acquired immunodeficiency syndrome	1.11e-05	0.000375	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—ALB—acquired immunodeficiency syndrome	1.07e-05	0.000362	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.03e-05	0.000348	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL2—acquired immunodeficiency syndrome	1.02e-05	0.000345	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CD4—acquired immunodeficiency syndrome	8.43e-06	0.000286	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.14e-06	0.000276	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ALB—acquired immunodeficiency syndrome	8.01e-06	0.000272	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ALB—acquired immunodeficiency syndrome	6.98e-06	0.000237	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.58e-06	0.000223	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL6—acquired immunodeficiency syndrome	5.98e-06	0.000203	CbGpPWpGaD
Vinblastine—ABCC1—Disease—IL6—acquired immunodeficiency syndrome	4.56e-06	0.000155	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.87e-06	0.000131	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	3.81e-06	0.000129	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	3.59e-06	0.000122	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.35e-06	7.96e-05	CbGpPWpGaD
